You are subscribed to the dvm360 Issue Alert.
Contact us | Subscriptions

Rx
Rx

Identification of inflammation and cardiac disease in everyday practice: CRP, SAA and NT-proBNP.

Tuesday, January 26 | 8 PM EST • 5 PM PST

______

Rx

 
Are you having problems with your in-house hematology? Come learn how in-clinic quantitative testing can change your lab.

Join Kendal Harr, DVM, MS, DACVP, and moderator Adam Christman, DVM, MBA, for tonight’s engaging webinar on cutting edge biomarker technology: C-reactive protein (CRP), serum amyloid A (SAA), and N-terminal pro-brain natriuretic peptide (NT-proBNP). You’ll discover the remarkable benefits of in-clinic quantitative testing and how it can change your lab.

Pharmaceutical Technology Pii

KENDAL HARR,
DVM, MS, DACVP

Pharmaceutical Technology Pii

ADAM CHRISTMAN,
DVM, MBA

      REGISTER NOW      

By attending, you will understand:

  • how CRP and SAA function in the body and the pathogenesis of these increased values;

  • how cutting-edge biomarker diagnostic technology can be used to diagnose inflammation;

  • pertinent handling of NT-proBNP critical to correct measurement;

  • remarkable benefits of in-clinic testing; and

  • much more.

This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.

      REGISTER      

Sponsored by:

Bionote
This email was sent by: %%Member_Busname%%
%%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%%


Privacy Policy

Update Profile      Manage Subscriptions      Unsubscribe